226
Participants
Start Date
April 8, 2024
Primary Completion Date
December 30, 2026
Study Completion Date
December 30, 2026
Edaravone dexborneol sublingual tablet
Patients will receive one edaravone dexborneol sublingual tablet twice daily for 24 weeks
Placebo
Patients will receive one placebo twice daily for 24 weeks
RECRUITING
Taihe County People's Hospital, Fuyang
RECRUITING
Hefei First People's Hospital, Hefei
RECRUITING
The First Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei
RECRUITING
The Second People's Hospital of Hefei, Hefei
RECRUITING
Huangshan City People's Hospital, Huangshan City
RECRUITING
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
RECRUITING
Wuzhou Red Cross Hospital, Wuzhou
RECRUITING
The Second Hospital of Hebei Medical University, Shijiazhuang
RECRUITING
Zhumadian Central Hospital, Zhumadian
RECRUITING
The Second Affiliated Hospital of Nanchang University, Nanchang
RECRUITING
The First Hospital of Jilin University, Changchun
RECRUITING
Liaoning Health Industry Group Bensteel General Hospital, Benxi
RECRUITING
The First Hospital of Dalian Medical University, Dalian
RECRUITING
The First People's Hospital of Shenyang, Shenyang
RECRUITING
Affiliated Hospital of Jining Medical College, Jining
RECRUITING
Liaocheng People's Hospital, Liaocheng
RECRUITING
Tai'an Central Hospital, Taian
RECRUITING
Suining Central Hospital, Suining
RECRUITING
Dongyang People's Hospital, Dongyang
RECRUITING
The First People's Hospital of Huzhou, Huzhou
RECRUITING
Zhuji People's Hospital of Zhejiang Province, Zhuji
Simcere Pharmaceutical Co., Ltd
OTHER